Overview: In June 2020 Japan's Packaged Medicaments exports accounted up to ¥36.2B and imports accounted up to ¥166B, resulting in a negative trade balance of ¥130B. Between June 2019 and June 2020 the exports of Japan's Packaged Medicaments have decreased by ¥-8.87B (-19.7%) from ¥45B to ¥36.2B, while imports increased by ¥20.2B (13.9%) from ¥146B to ¥166B.
Destinations: In June 2020 Packaged Medicaments exported mostly to United States (¥12.7B), China (¥9.87B), Taiwan (¥1.94B), South Korea (¥1.81B), and United Kingdom (¥1.72B), and imported mostly from Germany (¥32.1B), United States (¥18.1B), Puerto Rico (¥14.7B), Singapore (¥14.6B), and Canada (¥14.2B).
Growth: In June 2020, the decrease in Packaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to United States (¥-10.5B or -45.2%), Thailand (¥-434M or -35.4%), and Canada (¥-398M or -93.7%). In June 2020, the increase in Packaged Medicaments's year-by-year imports was explained primarily by an increase in imports from Canada (¥7.63B or 116%), Germany (¥7.37B or 29.7%), and United States (¥4.4B or 32.1%).